FDA RFO2- Cagayan Valley

13/04/2026

𝐎𝐍 𝐓𝐇𝐄 𝐆𝐑𝐎𝐔𝐍𝐃

𝘞𝘩𝘢𝘵 𝘥𝘰𝘦𝘴 𝘦𝘯𝘧𝘰𝘳𝘤𝘦𝘮𝘦𝘯𝘵 𝘭𝘰𝘰𝘬 𝘭𝘪𝘬𝘦 𝘪𝘯 𝘢𝘤𝘵𝘪𝘰𝘯?

With 𝟐,𝟎𝟖𝟓 𝐞𝐧𝐟𝐨𝐫𝐜𝐞𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 under the current leadership and ₱𝟕𝟓,𝟖𝟓𝟎,𝟒𝟗𝟎.𝟎𝟎 𝐰𝐨𝐫𝐭𝐡 𝐨𝐟 𝐯𝐢𝐨𝐥𝐚𝐭𝐢𝐯𝐞 𝐡𝐞𝐚𝐥𝐭𝐡 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐬𝐞𝐢𝐳𝐞𝐝 from January 2026 onwards, the FDA continues to intensify its regulatory enforcement against unsafe, substandard, and unregistered products in the market.

These actions underscore the Agency’s critical role in upholding compliance and deterring violations—ensuring that only properly evaluated and authorized health products reach the public. More than enforcement, this reflects a proactive and vigilant regulatory environment that protects consumers, strengthens inter-agency coordination, and reinforces accountability across the industry.

08/04/2026

07/04/2026

****Draft for Comments || Amendment to Administrative Order No. 2024-0012 Titled “Prescribing the Rules and Regulations on the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients Intended Solely for Export”****

All comments may be sent to [email protected] using the template provided. The deadline for submission of comments is on 05 June 2026.

I. RATIONALE

Republic Act (RA) No. 3720, otherwise known as “Foods, Drugs and Devices, and Cosmetics Act”, as amended by Executive Order No. 175 series of 1987, and further amended by RA No. 9711 or the “Food and Drug Administration (FDA) Act of 2009”, mandate the FDA to regulate health products through the issuance of appropriate authorizations prior to the manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, testing, promotion, advertisement, or sponsorship of any health product.

See more:-> https://tinyurl.com/mrnz8685

05/04/2026

𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐇𝐄𝐀𝐋𝐓𝐇, 𝐇𝐎𝐏𝐄, 𝐀𝐍𝐃 𝐑𝐄𝐍𝐄𝐖𝐀𝐋 𝐅𝐎𝐑 𝐄𝐕𝐄𝐑𝐘 𝐅𝐈𝐋𝐈𝐏𝐈𝐍𝐎

The Food and Drug Administration stands with the Filipino people in marking this meaningful occasion that signifies renewal, new beginnings, and the enduring strength of faith. As the culmination of Holy Week, this day is widely recognized as a celebration of life and the triumph of hope.

Across communities, families gather and traditions are observed in a spirit of joy and unity, reflecting a renewed sense of purpose and togetherness.

In this spirit, the FDA encourages everyone to carry forward values of care, responsibility, and compassion in our daily lives. May this occasion inspire continued commitment to protecting the health, safety, and well-being of every Filipino.

Let this celebration serve as a reminder that through shared responsibility and collective action, we move forward with optimism toward a healthier and stronger nation.

30/03/2026

Licensing Seminar for Drug Establishments (LS-D)

A licensing seminar for FDA Center for Drug Regulation and Research (CDRR) stakeholders which aims to provide information on the rules and regulations prescribing the requirements and procedures in the application for License to Operate (LTO) for drug establishments. The discussion also include current schedule of fees and charges and processing time.

Join our webinar on 21 May 2026 from 8:00 am to 12:00 nn via Google Meet
Registration fee: Php 500.00
Register through this link: bit.ly/4bOPPIK

Maximum of 800 participants
First-come-first-served basis

All successful registrants/applicants shall wait for the confirmation email from the FDA Academy for the issuance of Course Assessment Slip (CAS) and payment instruction pursuant to FDA Circular 2023-010.

Payments made without the corresponding CAS from the FDA Academy shall be forfeited.